单位：[1]CAMS, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China[2]PUMC, Beijing, Peoples R China[3]Geneplus Beijing Inst, Beijing, Peoples R China[4]Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China[5]Beijing Univ, Sch Oncol, Beijing Inst Canc Res, Beijing, Peoples R China[6]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[7]Shanghai Chest Hosp, Shanghai, Peoples R China[8]Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China[9]Jiangsu Prov Hosp, Nanjing, Peoples R China江苏省人民医院[10]Nanjing Univ, Drum Tower Hosp Affiliated, Sch Med, Ctr Comprehens Canc, Nanjing, Peoples R China[11]Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Fuzhou, Peoples R China[12]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China[13]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China江苏省人民医院[14]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China中山大学附属第二医院[15]Hangzhou Canc Hosp, Hangzhou, Peoples R China[16]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll Hust, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[17]Weill Cornell Sch Med, Houston Methodist Res Inst, Houston, TX USA
Ma Fei,Zhang Min,Ouyang Quchang,et al.ERBB2 mutation profiling with next-generation sequencing (NGS) in solid tumors[J].JOURNAL OF CLINICAL ONCOLOGY.2018,36(15):doi:10.1200/JCO.2018.36.15_suppl.e24264.
APA：
Ma, Fei,Zhang, Min,Ouyang, Quchang,Zhao, Jun,Dong, Xiaorong...&Xia, Xuefeng.(2018).ERBB2 mutation profiling with next-generation sequencing (NGS) in solid tumors.JOURNAL OF CLINICAL ONCOLOGY,36,(15)
MLA：
Ma, Fei,et al."ERBB2 mutation profiling with next-generation sequencing (NGS) in solid tumors".JOURNAL OF CLINICAL ONCOLOGY 36..15(2018)
医学